Create a narrative

AptarGroup Community

NYSE:ATR Community

1 Narratives written by author
0 Comments on narratives written by author
4 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 6 Analysts

Pharma, SmartTrack, Injectables And Beauty Will Open New Opportunities

Key Takeaways AptarGroup's Pharma and Beauty segments are poised for revenue growth due to strong demand, especially in sustainable products and drug delivery systems. Strategic expansions and share repurchases are expected to boost sales, earnings, and EPS growth, indicating confidence in future market opportunities.

US$173.67

FV

10.2% undervalued

6.14%

Revenue growth p.a.

0

0

3

10 days ago